APA (7th ed.) Citation

M, L., F, K., G, L., L, S., C, S., DJ, R., . . . JM, L. (2022). Characterizing the KRAS G12C mutation in metastatic colorectal cancer: A population-based cohort and assessment of expression differences in The Cancer Genome Atlas. Therapeutic advances in medical oncology, 14, 17588359221097940. https://doi.org/10.1177/17588359221097940

Chicago Style (17th ed.) Citation

M, Li, et al. "Characterizing the KRAS G12C Mutation in Metastatic Colorectal Cancer: A Population-based Cohort and Assessment of Expression Differences in The Cancer Genome Atlas." Therapeutic Advances in Medical Oncology 14 (2022): 17588359221097940. https://doi.org/10.1177/17588359221097940.

MLA (9th ed.) Citation

M, Li, et al. "Characterizing the KRAS G12C Mutation in Metastatic Colorectal Cancer: A Population-based Cohort and Assessment of Expression Differences in The Cancer Genome Atlas." Therapeutic Advances in Medical Oncology, vol. 14, 2022, p. 17588359221097940, https://doi.org/10.1177/17588359221097940.